CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Former FDA cancer chief Pazdur says the agency should restructure

Neutral
AI Analysis

Summary

Richard Pazdur, former FDA cancer drug review chief, says the agency has a 'golden opportunity' to restructure following the Trump administration's reduction in force last year.

Importance:3/10
Sentiment:
0.00
FDAregulatorycancer drugsrestructuringpersonnelpolicy

Read the original article

Published by Endpoints News on July 22, 2026 6:46 PM

Read Original